Glucagon-like peptide-1 receptor agonists (GLP-1RAs) improve glycaemic control, facilitate clinically meaningful weight loss, improve survival, and reduce the risk of renal failure and major adverse cardiovascular events
The medications slow gastric emptying so you feel full longer, reduce appetite signals in the brain, and improve how your body uses insulin
Thymosin Beta-4 (TB-500) Thymosin Beta-4 is a potent regenerative peptide that supports cellular repair, angiogenesis, and improved tissue resilience
David, wheres the cool noise
There are dozens of ongoing clinical trials exploring: New molecules : Next-generation GLP-1 agonists with longer duration, better safety, or oral administration (several oral semaglutide competitors are in trials)